Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyruvate in Cardiogenic Shock and IABP
NCT00604331Phase 2Completed
- Sponsor
- Herzzentrum Göttingen
- Start
- Aug 2008
- Primary completion
- Jul 2009
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Pyruvic acid in cardiogenic shock, heart failure (HF), sponsored by Herzzentrum Göttingen. Started Aug 2008; status: completed.
02
Drugs
Pyruvic acid
03
Conditions
cardiogenic shockheart failure (HF)
Beyond the preview
Go deeper on NCT00604331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604331.